Skip to main content
Back
Watch Compare

Emmaus Life Sciences, Inc.

Data quality: 100%
EMMA
OTC Manufacturing Chemicals
$0.01
▼ $0.01 (-33.33%)
Mkt Cap: 701,982.0
Price
$0.01
Mkt Cap
701,982.0
Day Range
$0.01 — $0.01
52-Week Range
$0.01 — $0.02
Volume
70,000
Open $0.01
50D / 200D Avg
$0.01
31.03% below
50D / 200D Avg
$0.01
21.88% below

Quick Summary

Key Takeaways

Revenue declined -11.83% annually over 5 years
Negative free cash flow of -12,000.0
Revenue growth is decelerating — 1Y growth trails 5Y average by 13.39%
Capital efficient — spends only 0.01% of revenue on capex
Interest coverage of 0.03× — tight debt servicing

Growth

Revenue Growth (5Y)
-11.83%
Below sector avg (1.82%)
Revenue (1Y)-25.22%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROICN/A
Net Margin-60.16%
Op. Margin1.85%

Safety

Debt / Equity
N/A
Current Ratio0.07
Interest Coverage0.03

Valuation

PE (TTM)
-0.09
Above sector avg (-1.48)
P/B RatioN/A
EV/EBITDA109.18
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -0.1 -1.5
P/B — 1.6
ROE % — -53.4
Net Margin % -60.2 -41.5
Rev Growth 5Y % -11.8 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -25.22% Revenue Growth (3Y) -35.13%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -11.83% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 12.45 M Net Income (TTM) -7.49 M
ROE N/A ROA -33.98%
Gross Margin 93.12% Operating Margin 1.85%
Net Margin -60.16% Free Cash Flow (TTM) -12,000.0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.07
Interest Coverage 0.03 Asset Turnover 0.56
Working Capital -59.38 M Tangible Book Value -59.49 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.09 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0.06
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 109.18 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -1.71%
Market Cap 701,982.0 Enterprise Value 29.48 M
Per Share
EPS (Diluted TTM) -0.12 Revenue / Share 0.18
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.01% FCF Conversion 0.16%
SBC-Adj. FCF -58,000 Growth Momentum -13.39

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 12.45 M 16.65 M 29.60 M 18.39 M 20.61 M
Net Income -7.49 M -6.45 M -3.73 M -10.63 M -15.95 M
EPS (Diluted) -0.12 -0.10 -0.07 -0.21 —
Gross Profit 11.60 M 15.45 M 28.26 M 15.80 M 17.30 M
Operating Income 231,000.0 -1.89 M 3.54 M -6.59 M -6.13 M
EBITDA — — — — —
R&D Expenses 313,000.0 657,000.0 1.19 M 1.73 M 4.11 M
SG&A Expenses — — — — —
D&A 39,000.0 22,000.0 32,000.0 53,000.0 59,000.0
Interest Expense 7.13 M 5.49 M 7.38 M 5.01 M 3.10 M
Income Tax 9,000.0 29,000.0 -59,000.0 60,000.0 25,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 21.44 M 23.60 M 35.18 M 48.23 M 56.73 M
Total Liabilities 85.04 M 80.08 M 82.94 M 82.32 M 78.18 M
Shareholders' Equity -63.61 M -56.48 M -47.76 M -34.09 M -21.45 M
Total Debt 27.13 M 28.97 M 30.56 M 30.42 M 22.34 M
Cash & Equivalents 2.13 M 1.39 M 2.55 M 2.02 M 2.28 M
Current Assets 7.75 M 6.77 M 11.51 M 6.29 M 9.09 M
Current Liabilities 69.07 M 63.56 M 61.51 M 54.32 M 37.10 M